NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 69.25% | 67.83% | 68.28% | 33.10% | 52.29% |
| Total Depreciation and Amortization | -71.78% | -56.44% | -13.48% | 1.76% | 10.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.17% | -22.75% | -8.63% | -22.93% | -22.21% |
| Change in Net Operating Assets | 77.81% | 94.81% | -152.96% | 8.39% | -94.04% |
| Cash from Operations | 65.63% | 80.33% | 47.57% | 38.62% | 48.57% |
| Capital Expenditure | -- | -- | 100.00% | 99.82% | 95.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 972.00% | 1,323.89% | 100.00% | -99.97% | -100.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.38% | 110.14% | 48.24% | -239.58% | -137.30% |
